Allen Richard Nissenson
Independent DirectorDr. Allen Richard Nissenson, M.D., FACP, FASN, FNKF, is Founder of Elicio Therapeutics, Inc. and also serves as Independent Director since June 01, 2023. He serves as Director at EasyDial Inc. since August 2021 and has been an Independent Director of Rockwell Medical, Inc. since June 11, 2020, which he joined in June 2020. Dr. Nissenson is a Member of the Board of Directors of Innocura Nephrology. He serves as a Member of the Medical Advisory Board at Sorbent Therapeutics, Inc. and as a Member of the Scientific Advisory Board of Intrinsic LifeSciences LLC. He is an Emeritus Professor of Medicine at the David Geffen School of Medicine at University California Los Angeles (UCLA) and serves as a Professor of Medicine of UCLA. He also serves as Editor-in-Chief of Hemodialysis International for Medscape. Dr. Nissenson served as an Emeritus Chief Medical Officer of DaVita Kidney Care from January 2020 to January 2022. He served as an Independent Non-Employee Director of Angion Biomedica Corp. from January 2020. He served as Chief Medical Officer of Kidney Care at DaVita HealthCare Partners Inc. from March 2014 to December 2019 and as Chief Medical Officer of DaVita Kidney Care from August 2008 to December 2019. He served as Chief Medical Officer at DaVita Clinical Research from August 2008 to December 2019 and was Chairman of its Scientific Advisory Board. Dr. Nissenson served as Chief Medical Officer of DaVita Inc. from August 1, 2008 to March 2014 and as a Special Advisor. He was employed at DaVita Inc. from August 1, 2008 to December 2019. He served as Associate Dean at UCLA from July 2005 to August 2008 and as Director of the Dialysis Program from July 1977 to August 2008. He served as a Robert Wood Johnson Health Policy Fellow of the National Academy of Medicine from 1994 to 1995. His other prior roles include Advisor at Ikigai Growth Partners, Member of the Strategic Advisory Board of Aevi Genomic Medicine, LLC, and Member of the Strategic Advisory Board of Medgenics, Inc. He served as National Medical Director of VillageHealth DM, LLC and was Chairman of its Medical Advisory Board. He was President of the Renal Physicians Association, President of the National Anemia Action Council (NAAC), and Chairman of the Southern California ESRD Network, where he also served as chair of the Medical Review Board. He was the immediate past Chair of Kidney Care Partners and co-chair of the Kidney Care Quality Alliance. He was the Founding Editor-in-Chief of Advances in Renal Replacement Therapy and served on the Dialysis Outcomes Quality Initiative of the National Kidney Foundation. Dr. Nissenson is a founder of RMS Disease Management Inc. and RMS Lifeline Inc. He also consulted for Rand Corporation and Pacificare. He served as Co-Principal Investigator of an NIH-sponsored Center on Health Disparities focused on kidney disease. In 2017, he received the RPA Distinguished Nephrology Service Award. He is also the recipient of the President's Award of the National Kidney Foundation, the Medal of Excellence Award, and the Lifetime Achievement Award in Hemodialysis. He has authored two dialysis textbooks and numerous publications in the fields of nephrology, dialysis, anemia management, and health care delivery and policy. His research as President-elect of the Southern California End-Stage Renal Disease Network has included clinical trials of new devices and drugs related to renal disease. Dr. Nissenson’s major research interests include a focus on the quality of care for chronic kidney disease patients, including issues of healthcare delivery, economics, and public policy; anemia management; the impact of anemia on brain and cognitive function; and the development of innovative new approaches to the treatment of CKD and ESRD patients. He received his B.S. from Northwestern University and his M.D. from the Northwestern University, Feinberg School of Medicine.
Positions
- Company NameRockwell Medical, Inc.Stock CodeRMTIPositionIndependent DirectorColleagues
- MSMark StrobeckPresident, CEO & Director
- RSRobert Samuel RadieIndependent Chairman
- JNJesse NeriSenior VP & CFO
- MCMegan C. TimminsExecutive VP, Chief Legal Officer & Secretary
- HHHeather H. HunterSenior VP & COO
- NFNicholas FanslauController & Principal Accounting Officer
- JGJohn G. CooperIndependent Director
- JMJoan M. LauIndependent Director
- Company NameElicio Therapeutics, Inc.Stock CodeELTXPositionFounder & Independent DirectorColleagues
- RTRobert T. ConnellyCEO, President & Director
- JAJulian AdamsIndependent Chairman & Member of Scientific Advisory Board
- ARAllen Richard NissensonFounder & Independent Director
- PSPreetam ShahChief Strategy & Financial Officer and Treasurer
- CMChristopher M. HaqqExecutive VP, Head of Research & Development and Chief Medical Officer
- DJDarrell J. IrvineCo-Founder, Consultant, Board Observer & Chairman of Scientific Advisory Board
- CGCarol Gail AsheIndependent Director
